PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 24.8 EUR Market Closed
Market Cap: 297.6m EUR

Wall Street
Price Targets

PSG Price Targets Summary
PharmaSGP Holding SE

Wall Street analysts forecast PSG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PSG is 39.53 EUR with a low forecast of 38.38 EUR and a high forecast of 41.48 EUR.

Lowest
Price Target
38.38 EUR
55% Upside
Average
Price Target
39.53 EUR
59% Upside
Highest
Price Target
41.48 EUR
67% Upside
PharmaSGP Holding SE Competitors:
Price Targets
KOTRA
Kotra Industries Bhd
32% Upside
SUVENPHAR
Suven Pharmaceuticals Ltd
30% Upside
SDZ
Sandoz Group AG
19% Upside
CORT
Corcept Therapeutics Inc
82% Upside
AETHER
Aether Industries Ltd
21% Upside
4521
Kaken Pharmaceutical Co Ltd
4% Upside

Revenue
Forecast

Revenue Estimate
PharmaSGP Holding SE

For the last 5 years the compound annual growth rate for PharmaSGP Holding SE's revenue is 11%. The projected CAGR for the next 4 years is 9%.

11%
Past Growth
9%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
PharmaSGP Holding SE

For the last 5 years the compound annual growth rate for PharmaSGP Holding SE's operating income is 5%. The projected CAGR for the next 4 years is 16%.

5%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
PharmaSGP Holding SE

For the last 5 years the compound annual growth rate for PharmaSGP Holding SE's net income is 2%. The projected CAGR for the next 3 years is 16%.

2%
Past Growth
16%
Estimated Growth
Estimates Accuracy
0%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PSG's stock price target?
Price Target
39.53 EUR

According to Wall Street analysts, the average 1-year price target for PSG is 39.53 EUR with a low forecast of 38.38 EUR and a high forecast of 41.48 EUR.

What is PharmaSGP Holding SE's Revenue forecast?
Projected CAGR
9%

For the last 5 years the compound annual growth rate for PharmaSGP Holding SE's revenue is 11%. The projected CAGR for the next 4 years is 9%.

What is PharmaSGP Holding SE's Operating Income forecast?
Projected CAGR
16%

For the last 5 years the compound annual growth rate for PharmaSGP Holding SE's operating income is 5%. The projected CAGR for the next 4 years is 16%.

What is PharmaSGP Holding SE's Net Income forecast?
Projected CAGR
16%

For the last 5 years the compound annual growth rate for PharmaSGP Holding SE's net income is 2%. The projected CAGR for the next 3 years is 16%.

Back to Top